0001948053-22-000001.txt : 20221129 0001948053-22-000001.hdr.sgml : 20221129 20221129163109 ACCESSION NUMBER: 0001948053-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221129 DATE AS OF CHANGE: 20221129 EFFECTIVENESS DATE: 20221129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Carmine Therapeutics, Inc. CENTRAL INDEX KEY: 0001948053 IRS NUMBER: 611943945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-466061 FILM NUMBER: 221433191 BUSINESS ADDRESS: STREET 1: 150 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 978-289-7076 MAIL ADDRESS: STREET 1: 150 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 D 1 primary_doc.xml X0708 D LIVE 0001948053 Carmine Therapeutics, Inc. 150 CAMBRIDGEPARK DRIVE CAMBRIDGE MA MASSACHUSETTS 02140 978-289-7076 DELAWARE None None Corporation true 2021 Donald Haut c/o Carmine Therapeutics, Inc. 150 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Executive Officer Director Harvey Lodish c/o Carmine Therapeutics, Inc. 150 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Director Lin Xiangqian c/o Carmine Therapeutics, Inc. 150 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Director Elan Ezickson c/o Carmine Therapeutics, Inc. 150 Cambridgepark Drive Cambridge MA MASSACHUSETTS 02140 Director Other Decline to Disclose 06b false 2022-08-24 false true false 0 13697828 13697828 0 false 6 0 0 0 false Carmine Therapeutics, Inc. /s/ Donald Haut Donald Haut Chief Executive Officer 2022-11-29